6. Di Guan C, Li P, Riggs PD, Inouye H. Vectors that facilitate the expression and purification of foreign peptides in Escherichia
coli by fusion to maltose-binding protein. Gene. 1988; 67:21–30.
7. Davis GD, Elisee C, Newham DM, Harrison RG. New fusion protein systems designed to give soluble expression in Escherichia
coli. Biotechnol. Bioeng. 1999; 65:382–388.
8. LaVallie ER, DiBlasio EA, Kovacic S, Grant KL, Schendel PF, McCoy JM. A thioredoxin gene fusion expression system that
circumvents inclusion body formation in the E. coli cytoplasm. Biotechnology. 1993; 11:187–193.
9. Gentz R, Certa U, Takacs B, Matile H, Döbeli H, Pink R, et al. Major surface antigen p190 of Plasmodium falciparum: Detection
of common epitopes present in a variety of plasmodia isolates. EMBO J. 1988; 7:225–230.
10. Hochuli E, Bannwarth W, Döbeli H, Gentz R, Stüber D. Genetic approach to facilitate purifaction of recombinant proteins
with a novel metal chelate adsorbent. Biotechnol. 1988; 6:1321–1325.
11. Smith MC, Furman TC, Ingolia TD, Pidgeon C. Chelating peptide-immobilized metal ion affinity chromatography. A new concept
in affinity chromatography for recombinant proteins. J. Biol. Chem. 1988; 263:7211–7215.
12. Malakhov MP, Mattern MR, Malakhova OA, Drinker M, Weeks SD, Butt TR. SUMO fusions and SUMO-specific protease for efficient
expression and purification of proteins. J. Struct. Funct. Genomics. 2004; 5:75–86.
13. Zuo X, Li S, Hall J, Mattern MR, Tran H, Shoo J, et al. Enhanced expression and purification of membrane proteins by
SUMO fusion in E. coli. J. Struct. Funct. Genomics. 2005; 6:103–111.
14. Zuo X, Mattern MR, Tan R, Li S, Hall J, Sterner DE, et al. Expression and purification of SARS Coronavirus proteins using
SUMO fusions. Protein Express Purif. 2005; 42:100–110.
15. Butt TR, Edavettal SC, Hall JP, Mattern MR. SUMO fusion technology for difficult-to-express proteins. Protein Express
Purif. 2005; 43:1–9.
16. Marblestone JG, Edavettal SC, Lim Y, Lim P, Zuo X, Butt TR. Comparison of SUMO fusion technology with traditional gene
fusion systems: Enhanced expression and solubility with SUMO. Protein Sci. 2006; 15:182–189.
17. Hammarstrom M, Hellgren N, van Den Berg S, Berglund H, Hard T. Rapid screening for improved solubility of small human
proteins produced as fusion proteins in Escherichia coli. Protein Sci. 2002; 11(2):313–321.
18. Braun P, Hu Y, Shen B, Halleck A, Koundinya M, Harlow E, LaBaer J. Proteome-scale purification of human proteins from
bacteria. Proc. Natl. Acad. Sci. 2002; 99(5):2654–2659.
19. Shih YP, Kung WM, Chen JC, Yeh CH, Wang AH, Wang TF. High-throughput screening of soluble recombinant proteins. Protein
Sci. 2002; 11(7):1714–1719.
20. Dyson MR, Shadbolt SP, Vincent KJ, Perera RL, McCafferty J. Production of soluble mammalian proteins in Escherichia coli:
identification of protein features that correlate with successful expression. BMC Biotechnol. 2004; 4:32.
21. De Marco V, Stier G, Blandin S, de Marco A. The solubility and stability of recombinant proteins are increased by their
fusion to NusA. Biochem. Biophys. Res. Commun. 2004; 322:766–771.
22. Sharma SK, Evans DB, Vosters AF, McQuade TJ, Tarpley WG. Metal affinity chromatography of recombinant HIV-1 reverse transcriptase
containing a human renin cleavable metal binding domain. Biotechnol. Appl. Biochem. 1991; 14:69–81.
|
